ReviewBMC neurology2026
Recurrent cerebral venous thrombosis associated with IgG4-related hypertrophic pachymeningitis: Case report and literature review.
Review in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
IgG4-related disease (IgG4-RD) is a systemic inflammatory condition marked by tissue infiltration of IgG4-positive plasma cells, often resulting in fibrosis. While IgG4-RD commonly affects organs such as the pancreas and salivary glands, central nervous system involvement, particularly hypertrophic pachymeningitis (HP), is rare and can present unique clinical challenges. This case report describes a 67-year-old male with IgG4-related hypertrophic pachymeningitis complicated by recurrent cerebral venous thrombosis (CVT), a rarely reported association. The patient initially responded to high-dose corticosteroids, but experienced symptom relapse upon tapering, necessitating treatment with rituximab for sustained disease control.In addition to presenting this case, we provide a comprehensive review of the literature on IgG4-RHP with CVT, analyzing clinical presentation, anatomical involvement, IgG4 serum levels, histopathological findings, treatment strategies, and outcomes across reported cases. Our analysis highlights the challenges of managing recurrent CVT in IgG4-RHP and underscores the importance of immunosuppressive therapy, particularly B-cell depletion, in achieving long-term disease stability. This case and literature review offer insights into the pathophysiology, diagnostic approach, and therapeutic considerations for this complex and rare manifestation of IgG4-RD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.